Reports for NATCO PHARMA (CANADA) INC

Company Name

NATCO PHARMA (CANADA) INC

Totals

Shortage reports

21

Actual shortage: 5 (24%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 16 (76%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

1 (5%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NAT-QUETIAPINE 100MG TABLET Resolved 2019-04-17 2022-07-01 81900
NAT-ERLOTINIB 100MG TABLET Actual shortage 2020-12-03 2024-02-02 129550
NATCO-CITALOPRAM 10MG TABLET Resolved 2018-11-23 2019-02-04 67518
NAT-RIZATRIPTAN ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67515
NAT-DONEPEZIL 10MG TABLET Resolved 2018-07-13 2020-10-26 55630
NAT-ESCITALOPRAM 10MG TABLET Resolved 2019-02-15 2020-10-26 75793
NAT-QUETIAPINE 150MG TABLET Resolved 2019-04-23 2021-10-31 82236
NAT-ERLOTINIB 150MG TABLET Actual shortage 2020-12-03 2024-02-02 129553
NAT-QUETIAPINE 200MG TABLET Resolved 2019-04-17 2022-07-01 81903
NAT-ESCITALOPRAM 20MG TABLET Resolved 2019-02-15 2020-10-26 75799
NAT-ESCITALOPRAM 20MG TABLET Actual shortage 2024-02-02 2024-02-03 218258
NAT-PREGABALIN 225MG CAPSULE Actual shortage 2023-05-17 2024-02-02 192650
NAT-LEVETIRACETAM 250MG TABLET Resolved 2019-02-15 2022-07-01 75810
NAT-QUETIAPINE 25MG TABLET Resolved 2018-10-31 2022-07-01 65944
NAT-ERLOTINIB 25MG TABLET Actual shortage 2020-12-03 2024-02-02 129536
NAT-QUETIAPINE 300MG TABLET Resolved 2019-04-17 2022-07-01 81906
NAT-LEVETIRACETAM 500MG TABLET Resolved 2018-10-19 2020-10-26 64878
NAT-RIZATRIPTAN ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-11-23 2019-02-07 67512
NAT-DONEPEZIL 5MG TABLET Resolved 2018-07-13 2020-10-26 55625
NAT-DONEPEZIL 5MG TABLET Resolved 2024-02-02 2024-02-21 218262

Showing 1 to 20 of 21

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0